Back to
BNP PARIBAS FINANCIAL MARKETS
NKTR5 quarters
Position history for
BNP PARIBAS FINANCIAL MARKETS's holdings in NEKTAR THERAPEUTICS
Yes. BNP Paribas Financial Markets holds 19,200 shares of NKTR (Nektar Therapeutics), worth $1.3M, as of its Q2 2026 13F filing. It reduced the position by 102,339 shares (-84.2%) from Q1 2026. BNP Paribas Financial Markets has held NKTR in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$1.3M
Current Shares
19,200
Total Value Change
+$1.3M
Total Shares Change
+18,976
Quarter-by-Quarter History
Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC